Valence Labs Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 40

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $35.9M

Valence Labs General Information

Description

Developer of artificial intelligence-based drug discovery platform designed to unlock small and noisy datasets. The company's platform uses bioinformatics and artificial intelligence to optimize the development of drugs through predictive analytics and work with the small and noisy datasets characteristic of low-throughput compound screens and late-stage lead optimization, enabling pharmaceutical companies to reduce the time, design, and optimize novel ligands against a broad range of precision medicine targets.

Contact Information

Formerly Known As
InVivo AI
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Mila-Quebec's AI Institute
  • 6666 Saint Urbain Street, Suite 200
  • Montreal, Quebec H2S 3H1
  • Canada
+1 (514)
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Other Healthcare Technology Systems
Parent Company
Vertical(s)
Big Data, Artificial Intelligence & Machine Learning, TMT, HealthTech
Corporate Office
  • Mila-Quebec's AI Institute
  • 6666 Saint Urbain Street, Suite 200
  • Montreal, Quebec H2S 3H1
  • Canada
+1 (514)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Valence Labs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 16-May-2023 $35.9M Completed Generating Revenue
10. Seed Round 19-Oct-2021 Completed Generating Revenue
9. Accelerator/Incubator 25-Nov-2019 Completed Generating Revenue
8. Early Stage VC (Series 1) 29-Sep-2019 Completed Generating Revenue
7. Accelerator/Incubator 01-Jan-2019 Completed Generating Revenue/Not Profitable
6. Accelerator/Incubator 10-Sep-2018 Completed Generating Revenue/Not Profitable
5. Accelerator/Incubator 08-Aug-2018 Completed Generating Revenue/Not Profitable
4. Grant 13-Jul-2018 Completed Generating Revenue/Not Profitable
3. Seed Round 01-Mar-2018 $1.59M $1.68M Completed Generating Revenue/Not Profitable
2. Accelerator/Incubator 09-Jan-2018 $94.7K $94.7K Completed Generating Revenue/Not Profitable
To view Valence Labs’s complete valuation and funding history, request access »

Valence Labs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Valence Labs Former Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds
Air Street Capital Venture Capital Minority
Amplify Capital Venture Capital Minority
Amplitude Ventures Venture Capital Minority
BoxOne Ventures Venture Capital Minority
Brian Karol Angel (individual) Minority
You’re viewing 5 of 21 investors. Get the full list »

Valence Labs FAQs

  • When was Valence Labs founded?

    Valence Labs was founded in 2018.

  • Where is Valence Labs headquartered?

    Valence Labs is headquartered in Montreal, Canada.

  • What is the size of Valence Labs?

    Valence Labs has 40 total employees.

  • What industry is Valence Labs in?

    Valence Labs’s primary industry is Drug Discovery.

  • Is Valence Labs a private or public company?

    Valence Labs is a Private company.

  • What is the current valuation of Valence Labs?

    The current valuation of Valence Labs is .

  • What is Valence Labs’s current revenue?

    The current revenue for Valence Labs is .

  • How much funding has Valence Labs raised over time?

    Valence Labs has raised $10.2M.

  • Who are Valence Labs’s investors?

    Air Street Capital, Amplify Capital, Amplitude Ventures, BoxOne Ventures, and Brian Karol are 5 of 21 investors who have invested in Valence Labs.

  • When was Valence Labs acquired?

    Valence Labs was acquired on 16-May-2023.

  • Who acquired Valence Labs?

    Valence Labs was acquired by Recursion Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »